Shanghai MicroPort Rhythm MedTech Co., Ltd.
Clinical trials sponsored by Shanghai MicroPort Rhythm MedTech Co., Ltd., explained in plain language.
Develops cardiac rhythm management devices such as pacemakers.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Laser precision: new device aims to clear heart blockages before stenting Results expected Jun 2027 (estimated)
-
Laser precision: new device aims to clear heart blockages before stenting
Disease control Not yet recruitingThis study tests a new laser system designed to vaporize plaque in blocked coronary arteries before doctors place a stent. The trial compares the new laser device to an existing one in about 218 people with severe heart artery narrowing. The main goal is to see if the new system …
Sponsor: Shanghai MicroPort Rhythm MedTech Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Balloon pump in heart vein may limit damage after heart attack
Disease control Not yet recruitingThis study tests if a special balloon pump placed in a heart vein (coronary sinus) can reduce heart muscle damage when used alongside standard angioplasty in people having a major heart attack (STEMI). About 177 adults aged 18-80 with moderate heart pumping weakness will be rando…
Sponsor: Shanghai MicroPort Rhythm MedTech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC